Your browser doesn't support javascript.
BNT162b2 vaccine effectiveness against SARS-CoV-2 omicron BA.4 and BA.5.
Tartof, Sara Y; Slezak, Jeff M; Puzniak, Laura; Hong, Vennis; Frankland, Timothy B; Ackerson, Bradley K; Takhar, Harpreet; Ogun, Oluwaseye A; Simmons, Sarah; Zamparo, Joann M; Jodar, Luis; McLaughlin, John M.
  • Tartof SY; Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, CA 91101, USA; Department of Health Systems Science, Kaiser Permanente Bernard J Tyson School of Medicine, Pasadena, CA USA. Electronic address: sara.y.tartof@kp.org.
  • Slezak JM; Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, CA 91101, USA.
  • Puzniak L; Pfizer, Collegeville, PA, USA.
  • Hong V; Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, CA 91101, USA.
  • Frankland TB; Kaiser Permanente Hawaii Center for Integrated Health Care Research, Honolulu, HI, USA.
  • Ackerson BK; Southern California Permanente Medical Group, Harbor City, CA, USA.
  • Takhar H; Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, CA 91101, USA.
  • Ogun OA; Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, CA 91101, USA.
  • Simmons S; Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, CA 91101, USA.
  • Zamparo JM; Pfizer, Collegeville, PA, USA.
  • Jodar L; Pfizer, Collegeville, PA, USA.
  • McLaughlin JM; Pfizer, Collegeville, PA, USA.
Lancet Infect Dis ; 22(12): 1663-1665, 2022 Dec.
Article in English | MEDLINE | ID: covidwho-2096185

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Experimental Studies Topics: Vaccines / Variants Limits: Humans Language: English Journal: Lancet Infect Dis Journal subject: Communicable Diseases Year: 2022 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Experimental Studies Topics: Vaccines / Variants Limits: Humans Language: English Journal: Lancet Infect Dis Journal subject: Communicable Diseases Year: 2022 Document Type: Article